Milestone Pharmaceuticals Inc

NASDAQ:MIST   3:59:44 PM EDT
6.68
0.00 (0.00%)
Earnings Announcements

Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results And Provides Clinical And Corporate Update

Published: 11/13/2020 12:14 GMT
Milestone Pharmaceuticals Inc. (MIST) - Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update.
Milestone Pharmaceuticals Inc - on Track to Reopen Enrollment in Pivotal Phase 3 Rapid Trial by Year-end.
Milestone Pharmaceuticals Inc Qtrly Loss per Share 40 Cents.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.46

More details on our Analysts Page.